Coagulation Testing Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global coagulation testing market looks promising with opportunities in activated clotting time (ACT), thrombin time (TT), partial thromboplastin time (PTT), activated partial thromboplastin time (aPTT), and prothrombin time (PT) applications. The global coagulation testing market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are rising prevalence of blood disorders & cardiovascular diseases, increasing geriatric population, and advancement in technologies, such as easy-to-use and faster devices with advanced sensor technology.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global coagulation testing market report, please download the report brochure.
In this market, consumables is the largest product of coagulation testing, whereas hospitals is the largest end user. Growth in various segments of the coagulation testing market are given below:
The study includes trends and forecast for the global coagulation testing market by product, technology, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Instruments
Consumables
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Optical Technology
Mechanical Technology
Electrochemical Technology
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Activated Clotting Time
Thrombin Time
Partial Thromboplastin Time
Activated Partial Thromboplastin Time
Prothrombin Time
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Spain
German
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the coagulation testing companies profiled in this report include Alere, Nihon Kohden, Roche, Sysmex, Thermo Fisher Scientific, Diagnostica Stago, Helena Laboratories, Abbott Laboratories, Medtronic, and Micropoint Biosciences.
Lucintel forecasts that consumables will remain the largest product segment over the forecast period due to increasing research and development activities related to analyzers and rising technological advancements.
Within this market, hospitals will remain the largest end user segment over the forecast period due to increasing demand for comprehensive medical care and new innovation in therapeutic techniques.
Asia Pacific is expected to witness the highest growth over the forecast period due to increasing cases of blood disorders, growing geriatric population, and rising healthcare spending in the region.
Features of the Global Coagulation Testing Market
Market Size Estimates: Global coagulation testing market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global coagulation testing market size by various segments, such as product, technology, application, and end user in terms of value.Regional Analysis: Global coagulation testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, technology, application, end user, and region for the global coagulation testing market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global coagulation testing market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global coagulation testing market by product (instruments and consumables), technology (optical technology, mechanical technology, and electrochemical technology), application (activated clotting time, thrombin time, partial thromboplastin time, activated partial thromboplastin time, and prothrombin time), end user (hospitals, clinical laboratories, and point-of-care testing), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global coagulation testing market?
Q.5 What are the business risks and threats to the global coagulation testing market?
Q.6 What are emerging trends in this coagulation testing market and the reasons behind them?
Q.7 What are some changing demands of customers in this coagulation testing market?
Q.8 What are the new developments in this coagulation testing market? Which companies are leading these developments?
Q.9 Who are the major players in this coagulation testing market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this coagulation testing market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global coagulation testing market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Instruments and Consumables), Technology (Optical Technology, Mechanical Technology, and Electrochemical Technology), Application (Activated Clotting Time, Thrombin Time, Partial Thromboplastin Time, Activated Partial Thromboplastin Time, and Prothrombin Time), and End User (Hospitals, Clinical Laboratories, and Point-of-Care Testing)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global coagulation testing market looks promising with opportunities in activated clotting time (ACT), thrombin time (TT), partial thromboplastin time (PTT), activated partial thromboplastin time (aPTT), and prothrombin time (PT) applications. The global coagulation testing market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are rising prevalence of blood disorders & cardiovascular diseases, increasing geriatric population, and advancement in technologies, such as easy-to-use and faster devices with advanced sensor technology.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global coagulation testing market report, please download the report brochure.
In this market, consumables is the largest product of coagulation testing, whereas hospitals is the largest end user. Growth in various segments of the coagulation testing market are given below:
The study includes trends and forecast for the global coagulation testing market by product, technology, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Instruments
Consumables
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Optical Technology
Mechanical Technology
Electrochemical Technology
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Activated Clotting Time
Thrombin Time
Partial Thromboplastin Time
Activated Partial Thromboplastin Time
Prothrombin Time
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Spain
German
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the coagulation testing companies profiled in this report include Alere, Nihon Kohden, Roche, Sysmex, Thermo Fisher Scientific, Diagnostica Stago, Helena Laboratories, Abbott Laboratories, Medtronic, and Micropoint Biosciences.
Lucintel forecasts that consumables will remain the largest product segment over the forecast period due to increasing research and development activities related to analyzers and rising technological advancements.
Within this market, hospitals will remain the largest end user segment over the forecast period due to increasing demand for comprehensive medical care and new innovation in therapeutic techniques.
Asia Pacific is expected to witness the highest growth over the forecast period due to increasing cases of blood disorders, growing geriatric population, and rising healthcare spending in the region.
Features of the Global Coagulation Testing Market
Market Size Estimates: Global coagulation testing market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global coagulation testing market size by various segments, such as product, technology, application, and end user in terms of value.Regional Analysis: Global coagulation testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, technology, application, end user, and region for the global coagulation testing market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global coagulation testing market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global coagulation testing market by product (instruments and consumables), technology (optical technology, mechanical technology, and electrochemical technology), application (activated clotting time, thrombin time, partial thromboplastin time, activated partial thromboplastin time, and prothrombin time), end user (hospitals, clinical laboratories, and point-of-care testing), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global coagulation testing market?
Q.5 What are the business risks and threats to the global coagulation testing market?
Q.6 What are emerging trends in this coagulation testing market and the reasons behind them?
Q.7 What are some changing demands of customers in this coagulation testing market?
Q.8 What are the new developments in this coagulation testing market? Which companies are leading these developments?
Q.9 Who are the major players in this coagulation testing market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this coagulation testing market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global coagulation testing market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Instruments and Consumables), Technology (Optical Technology, Mechanical Technology, and Electrochemical Technology), Application (Activated Clotting Time, Thrombin Time, Partial Thromboplastin Time, Activated Partial Thromboplastin Time, and Prothrombin Time), and End User (Hospitals, Clinical Laboratories, and Point-of-Care Testing)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Coagulation Testing Market Trends and Forecast
3.3: Global Coagulation Testing Market by Product
3.3.1: Instruments
3.3.2: Consumables
3.4: Global Coagulation Testing Market by Technology
3.4.1: Optical Technology
3.4.2: Mechanical Technology
3.4.3: Electrochemical Technology
3.5: Global Coagulation Testing Market by Application
3.5.1: Activated Clotting Time (ACT)
3.5.2: Thrombin Time (TT)
3.5.3: Partial Thromboplastin Time (PTT)
3.5.4: Activated Partial Thromboplastin Time (aPTT)
3.5.5: Prothrombin Time (PT)
3.6: Global Coagulation Testing Market by End User
3.6.1: Hospitals
3.6.2: Clinical Laboratories
3.6.3: Point-Of-Care Testing
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Coagulation Testing Market by Region
4.2: North American Coagulation Testing Market
4.2.1: Market by Product: Instruments and Consumables
4.2.2: Market by Technology: Optical Technology, Mechanical Technology, and Electrochemical Technology
4.2.3: Market by Application: Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (aPTT), and Prothrombin Time (PT)
4.2.4: Market by End User: Hospitals, Clinical Laboratories, and Point-Of-Care Testing
4.2.5: The United States Coagulation Testing Market
4.2.6: The Canadian Coagulation Testing Market
4.2.7: The Mexican Coagulation Testing Market
4.3: European Coagulation Testing Market
4.3.1: Market by Product: Instruments and Consumables
4.3.2: Market by Technology: Optical Technology, Mechanical Technology, and Electrochemical Technology
4.3.3: Market by Application: Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (aPTT), and Prothrombin Time (PT)
4.3.4: Market by End User: Hospitals, Clinical Laboratories, and Point-Of-Care Testing
4.3.5: The Coagulation Testing Market of United Kingdom
4.3.6: The Spanish Coagulation Testing Market
4.3.7: The German Coagulation Testing Market
4.3.8: The French Coagulation Testing Market
4.4: APAC Coagulation Testing Market
4.4.1: Market by Product: Instruments and Consumables
4.4.2: Market by Technology: Optical Technology, Mechanical Technology, and Electrochemical Technology
4.4.3: Market by Application: Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (aPTT), and Prothrombin Time (PT)
4.4.4: Market by End User: Hospitals, Clinical Laboratories, and Point-Of-Care Testing
4.4.5: The Chinese Coagulation Testing Market
4.4.6: The Indian Coagulation Testing Market
4.4.7: The Japanese Coagulation Testing Market
4.5: ROW Coagulation Testing Market
4.5.1: Market by Product: Instruments and Consumables
4.5.2: Market by Technology: Optical Technology, Mechanical Technology, and Electrochemical Technology
4.5.3: Market by Application: Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (aPTT), and Prothrombin Time (PT)
4.5.4: Market by End User: Hospitals, Clinical Laboratories, and Point-Of-Care Testing
4.5.5: Brazilian Coagulation Testing Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2:SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Coagulation Testing Market by Product
7.1.2: Growth Opportunities for the Global Coagulation Testing Market by Technology
7.1.3: Growth Opportunities for the Global Coagulation Testing Market by Application
7.1.4: Growth Opportunities for the Global Coagulation Testing Market by End User
7.1.5:Growth Opportunities for the Global Coagulation Testing Market by Region
7.2: Emerging Trends in the Global Coagulation Testing Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Coagulation Testing Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Coagulation Testing Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Alere Inc.
8.2: Nihon Kohden Corporation
8.3: F. Hoffmann-La Roche Ltd.
8.4: Sysmex Corporation
8.5: Therm Fisher Scientific Inc.
8.6: Diagnostica Stag S.A.S.
8.7: Helena Laboratories
8.8: Abbott Laboratories
8.9: Medtronic plc
8.10: Micropoint Biosciences
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Coagulation Testing Market Trends and Forecast
3.3: Global Coagulation Testing Market by Product
3.3.1: Instruments
3.3.2: Consumables
3.4: Global Coagulation Testing Market by Technology
3.4.1: Optical Technology
3.4.2: Mechanical Technology
3.4.3: Electrochemical Technology
3.5: Global Coagulation Testing Market by Application
3.5.1: Activated Clotting Time (ACT)
3.5.2: Thrombin Time (TT)
3.5.3: Partial Thromboplastin Time (PTT)
3.5.4: Activated Partial Thromboplastin Time (aPTT)
3.5.5: Prothrombin Time (PT)
3.6: Global Coagulation Testing Market by End User
3.6.1: Hospitals
3.6.2: Clinical Laboratories
3.6.3: Point-Of-Care Testing
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Coagulation Testing Market by Region
4.2: North American Coagulation Testing Market
4.2.1: Market by Product: Instruments and Consumables
4.2.2: Market by Technology: Optical Technology, Mechanical Technology, and Electrochemical Technology
4.2.3: Market by Application: Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (aPTT), and Prothrombin Time (PT)
4.2.4: Market by End User: Hospitals, Clinical Laboratories, and Point-Of-Care Testing
4.2.5: The United States Coagulation Testing Market
4.2.6: The Canadian Coagulation Testing Market
4.2.7: The Mexican Coagulation Testing Market
4.3: European Coagulation Testing Market
4.3.1: Market by Product: Instruments and Consumables
4.3.2: Market by Technology: Optical Technology, Mechanical Technology, and Electrochemical Technology
4.3.3: Market by Application: Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (aPTT), and Prothrombin Time (PT)
4.3.4: Market by End User: Hospitals, Clinical Laboratories, and Point-Of-Care Testing
4.3.5: The Coagulation Testing Market of United Kingdom
4.3.6: The Spanish Coagulation Testing Market
4.3.7: The German Coagulation Testing Market
4.3.8: The French Coagulation Testing Market
4.4: APAC Coagulation Testing Market
4.4.1: Market by Product: Instruments and Consumables
4.4.2: Market by Technology: Optical Technology, Mechanical Technology, and Electrochemical Technology
4.4.3: Market by Application: Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (aPTT), and Prothrombin Time (PT)
4.4.4: Market by End User: Hospitals, Clinical Laboratories, and Point-Of-Care Testing
4.4.5: The Chinese Coagulation Testing Market
4.4.6: The Indian Coagulation Testing Market
4.4.7: The Japanese Coagulation Testing Market
4.5: ROW Coagulation Testing Market
4.5.1: Market by Product: Instruments and Consumables
4.5.2: Market by Technology: Optical Technology, Mechanical Technology, and Electrochemical Technology
4.5.3: Market by Application: Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (aPTT), and Prothrombin Time (PT)
4.5.4: Market by End User: Hospitals, Clinical Laboratories, and Point-Of-Care Testing
4.5.5: Brazilian Coagulation Testing Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2:SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Coagulation Testing Market by Product
7.1.2: Growth Opportunities for the Global Coagulation Testing Market by Technology
7.1.3: Growth Opportunities for the Global Coagulation Testing Market by Application
7.1.4: Growth Opportunities for the Global Coagulation Testing Market by End User
7.1.5:Growth Opportunities for the Global Coagulation Testing Market by Region
7.2: Emerging Trends in the Global Coagulation Testing Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Coagulation Testing Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Coagulation Testing Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Alere Inc.
8.2: Nihon Kohden Corporation
8.3: F. Hoffmann-La Roche Ltd.
8.4: Sysmex Corporation
8.5: Therm Fisher Scientific Inc.
8.6: Diagnostica Stag S.A.S.
8.7: Helena Laboratories
8.8: Abbott Laboratories
8.9: Medtronic plc
8.10: Micropoint Biosciences
